Dr. Albittar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6720 Bertner Ave
Houston, TX 77030Phone+1 713-798-2222
Education & Training
University of WashingtonResidency, Internal Medicine, 2021 - 2023
SUNY Upstate Medical UniversityInternship, Internal Medicine, 2020 - 2021
Faculty of Medicine of Albaath UniversityClass of 2018
Certifications & Licensure
TX State Medical License 2023 - 2025
WA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Development and validation of predictive models of early immune effector cell-associated hematotoxicity (eIPMs).Emily C Liang, Jennifer J Huang, Andrew J Portuguese, Valentín Ortiz-Maldonado, Aya Albittar
Blood Advances. 2024-12-03 - Correction: Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity.Emily C Liang, Kai Rejeski, Teng Fei, Aya Albittar, Jennifer J Huang
Bone Marrow Transplantation. 2024-11-12 - A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma.Mohamed A Gouda, Bettzy Stephen, Yanyan Tian, Anas Alshawa, Dilichukwu O Chudy Onwugaje
Journal of Immunotherapy and Precision Oncology. 2024-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
